Specifically, the inhibition of EHMT2 and TGF-β1 resulted in increased expression of NKG2D ligands (ULBP3 and MICB) on cancer cells in an autocrine manner, resulting in enhanced NK cell-mediated cytotoxicity. Here, ULBP3 is linked to cancer.